COVID-19 expedites India's focus on innovation within pharma
By MYBRANDBOOK
The COVID-19 pandemic has pushed India to expedite focus on pharma research and development (R&D) to become more independent. The hope of getting indigenous COVID-19 vaccines has boosted the government's confidence towards indigenous research and development and this momentum should continue, says GlobalData, a leading data analytics and research company.
India is expected to unveil a new Pharma Research and Development policy soon to incentivize scientists based on the monetization of their innovations. According to the Global Innovation Index, India has moved up four places to 48 in the overall ranking across sectors in 2020.
Moreover, the government is willing to focus on industry-academia linkage to translate research into the development and the commercialization of technologies while promoting research towards new drug discovery.
Prashant Khadayate, Pharma Analyst at GlobalData, comments: “India is working on infrastructure to accelerate R&D in India. Hopefully, the new policy will provide incentives that will accelerate R&D. It could act as a key milestone to turnaround the overall R&D environment within the Indian pharma industry.”
In 2019, the Department of Pharmaceuticals (DoP) outlined a drug discovery scheme. However, the production-linked incentive (PLI) scheme for the active pharmaceutical ingredients was prioritized over the drug discovery scheme during the COVID-19 pandemic. The DoP set up an inter-departmental committee to coordinate R&D activities undertaken by various top institutions such as the Indian Institutes of Technology (IITs), the National Institutes of Pharmaceutical Education and Research (NIPERs), and the Biotechnology Industry Research Assistance Council (BIRAC).
According to GlobalData’s Pharma Intelligence Center, Bharat Biotech (in partnership with the Indian Council of Medical Research (ICMR)) and Zydus Cadila are leading the race for indigenous vaccine development in India. Bharat Biotech vaccine Covaxin is in Phase III and the company has filed for its emergency use authorization (EUA), whereas Zydus Cadila’s vaccine ZyCoV-D is expected to enter Phase III in December 2020.
In July 2020, a first-of-its-kind Drug Discovery Hackathon project was initiated to develop an anti-COVID drug. This hackathon is a national initiative to support the drug discovery process and invited the participation of professionals, faculty, researchers, and students from varied fields like computer science, chemistry, pharmacy, medical sciences, basic sciences and biotechnology.
Mr Khadayate concludes: “Indigenous vaccines’ development progress by Indian companies in a short turnaround time has proven their capability in the innovation space on par with global companies. However, the government support will help in improving the overall environment towards research and development.”
Nazara and ONDC set to transform in-game monetization with ‘
Nazara Technologies has teamed up with the Open Network for Digital Comme...
Jio Platforms and NICSI to offer cloud services to government
In a collaborative initiative, the National Informatics Centre Services In...
BSNL awards ₹5,000 Cr Project to RVNL-Led Consortium
A syndicate led by Rail Vikas Nigam Limited (abbreviated as RVNL), along wi...
Pinterest tracks users without consent, alleges complaint
A recent complaint alleges that Pinterest, the popular image-sharing platf...
DATA SAFEGUARD INDIA PRIVATE LIMITED
STERLITE TECHNOLOGIES LTD.
INFOSYS TECHNOLOGIES PVT. LTD.
TATA CONSULTANCY SERVICES
ICONS OF INDIA : ROSHNI NADAR MALHOTRA
Roshni Nadar Malhotra is the Chairperson of HCLTech, a leading global ...
Icons Of India : Dilip Asbe
At present, Dilip Asbe is heading National Payments Corporation of Ind...
Icons Of India : Arundhati Bhattacharya
Arundhati Bhattacharya serves as the Chairperson and CEO of Salesforce...
NIC - National Informatics Centre
NIC serves as the primary IT solutions provider for the government of ...
BEL - Bharat Electronics Limited
BEL is an Indian Government-owned aerospace and defence electronics co...
RailTel Corporation of India Limited
RailTel is a leading telecommunications infrastructure provider in Ind...
Indian Tech Talent Excelling The Tech World - George Kurian, CEO, Netapp
George Kurian, the CEO of global data storage and management services ...
Indian Tech Talent Excelling The Tech World - Steve Sanghi, Executive Chair, Microchip
Steve Sanghi, the Executive Chair of Microchip Technology, has been a ...
Indian Tech Talent Excelling The Tech World - Thomas Kurian, CEO- Google Cloud
Thomas Kurian, the CEO of Google Cloud, has been instrumental in expan...